octreotide injection

摘要

the present invention relates to a sterile solution comprising: octreotide in the form of a pharmaceutically acceptable salt, present at a concentration equivalent to 2.0 mg / ml to 2.5 mg / ml of octreotide base, and at least one preservative in a pharmaceutically acceptable vehicle, where the sterile solution is present in an injection device.